PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-72

  1. 613 Posts.
    lightbulb Created with Sketch. 293
    I agree Tanimirod, if they had someone it would be done. No way would all the BP be waiting it is a fantasy to suggest otherwise. PR has allowed this infact forced it to happen, this is what happens when there is no and I mean no zero Governance in place. He answers to no one so now we are led to believe that FDA approval will fix everything. Well what if? That’s it there is no room for what ifs, ask REX. Simple as that can’t trade if insolvent and we are a bees dick away from that, hopium doesn’t cut it in business, regardless of product.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.